STOCK TITAN

[144] Hims & Hers Health, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Hims & Hers Health, Inc. notice reports a proposed sale of 900 Class A shares through Fidelity Brokerage Services LLC on 10/10/2025 with an aggregate market value of $52,425. The filer indicates the shares derive from an option granted on 08/10/2022 and show cash payment on the stated sale date. The filing lists recent insider sales by Michael Y. Chi totaling $4,240,268.50 across eight transactions between 07/23/2025 and 10/01/2025.

The notice includes the required representation that the seller does not possess undisclosed material adverse information and identifies this as a Rule 144 notice of proposed sale. No earnings, guidance, or other operational metrics are disclosed in this form.

Hims & Hers Health, Inc. notifica una vendita proposta di 900 Class A azioni tramite Fidelity Brokerage Services LLC in data 10/10/2025 con un valore di mercato aggregato di $52,425. Il dichiaratore indica che le azioni derivano da una opzione concessa il 08/10/2022 e mostrano pagamento in contanti nella data di vendita indicata. La pratica elenca recenti vendite di insider da Michael Y. Chi per un totale di $4,240,268.50 attraverso otto transazioni tra 07/23/2025 e 10/01/2025.

La notifica include la rappresentazione richiesta secondo cui il venditore non possiede informazioni materiali avverse non divulgate e identifica questa come una notifica di vendita proposta ai sensi della Rule 144. Nessun utile, guidance o altre metriche operative sono divulgate in questa forma.

Hims & Hers Health, Inc. aviso reporta una venta propuesta de 900 Class A acciones a través de Fidelity Brokerage Services LLC en 10/10/2025 con un valor de mercado agregado de $52,425. El declarante indica que las acciones provienen de una opción otorgada el 08/10/2022 y muestran pago en efectivo en la fecha de venta indicada. El registro lista ventas internas recientes por Michael Y. Chi por un total de $4,240,268.50 a través de ocho transacciones entre 07/23/2025 y 10/01/2025.

La notificación incluye la representación requerida de que el vendedor no posee información material adversa no divulgada e identifica esto como una noticia de venta propuesta conforme a la Regla 144. No se divulgan ganancias, directrices u otras métricas operativas en este formulario.

Hims & Hers Health, Inc. 공지는 Fidelity Brokerage Services LLC를 통해 900 Class A 주식을 2025/10/10에 매도할 것을 제안하며 총 시장 가치는 $52,425입니다. 제출자는 주식이 2022년 8월 10일에 부여된 옵션에서 파생되었으며 명시된 매도일에 현금 지급이 이루어짐을 표시합니다. 제출서는 Michael Y. Chi의 최근 내부자 매도가 $4,240,268.50에 이르고 8건의 거래에 걸쳐 07/23/2025 부터 10/01/2025 사이에 이루어졌다고 목록화합니다.

통지에는 매도인이 공개되지 않은 중요한 악재 정보가 없다는 요건적 진술이 포함되며 이를 Rule 144 매도 예고로 식별합니다. 수익, 가이던스 또는 다른 운영 지표는 이 양식에 기재되어 있지 않습니다.

Hims & Hers Health, Inc. notification informe d'une vente proposée de 900 Class A actions par l'intermédiaire de Fidelity Brokerage Services LLC le 10/10/2025 avec une valeur marchande $52,425 au total. Le déposant indique que les actions proviennent d'une option accordée le 08/10/2022 et montrent un paiement en espèces à la date de vente indiquée. Le dossier répertorie des ventes internes récentes par Michael Y. Chi pour un total de $4,240,268.50 réparties sur huit transactions entre 07/23/2025 et 10/01/2025.

L'avis comprend la représentation requise selon laquelle le vendeur ne possède pas d'informations matérielles défavorables non divulguées et l'identifie comme un avis de vente proposée conformément à la Rule 144. Aucun bénéfice, orientation ou autres métriques opérationnelles ne sont divulgués dans ce formulaire.

Hims & Hers Health, Inc. Mitteilung meldet einen vorgesehenen Verkauf von 900 Class A-Aktien über Fidelity Brokerage Services LLC am 10.10.2025 mit einem aggregierten Marktwert von $52,425. Der Einreicher gibt an, dass die Aktien aus einer am 08/10/2022 gewährten Option stammen und am angegebenen Verkaufstag eine Barzahlung zeigen. Die Einreichung listet jüngste Insiderverkäufe von Michael Y. Chi in Höhe von $4,240,268.50 über acht Transaktionen zwischen 07/23/2025 und 10/01/2025 auf.

Die Mitteilung enthält die erforderliche Darstellung, dass der Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen besitzt und kennzeichnet dies als eine Rule 144-Mitteilung über den geplanten Verkauf. In diesem Formular werden weder Erträge, Guidance noch andere operative Kennzahlen offengelegt.

Hims & Hers Health, Inc. إشعار يُبلغ عن بيع مقترح لـ 900 Class A سهم من خلال Fidelity Brokerage Services LLC في 10/10/2025 بقيمة سوقية إجمالية قدرها $52,425. يذكر مقدم الإيداع أن الأسهم مستمدة من خيار مُمنوح في 08/10/2022 ويظهر دفعاً نقدياً في تاريخ البيع المذكور. يسجل الإيداع مبيعات داخلية حديثة من Michael Y. Chi بإجمالي $4,240,268.50 عبر ثمانية معاملات بين 07/23/2025 و10/01/2025.

يتضمن الإشعار التمثيل المطلوب بأن البائع لا يمتلك معلومات مادية غير مُعلنة ويحدد ذلك كإخطار بيع مقترح وفقاً للقواعد 144. لا يُكشف عن أرباح أو توجيهات أو مقاييس تشغيلية أخرى في هذا النموذج.

Hims & Hers Health, Inc. 通知报告通过 Fidelity Brokerage Services LLC2025/10/10900 Class A 股,市场总值为 $52,425。申报人表示这些股票来自于 在 2022 年 8 月 10 日授予的期权,并在指定的出售日期显示现金支付。申报记录显示由 Michael Y. Chi 的最近内部交易,总额为 $4,240,268.50,跨越八笔交易,时间段为 2025/07/232025/10/01

通知包含所需的声明,即卖方不持有未披露的重大不利信息,并将其标识为符合 Rule 144 的拟议出售通知。本表格未披露任何收益、指引或其他运营指标。

Positive
  • Transparency of planned sale via Form 144 with broker and sale date disclosed
  • Shares originate from documented option grant (granted 08/10/2022) showing standard vesting/exercise mechanics
Negative
  • Multiple recent insider sales totaling $4,240,268.50 may signal ongoing insider liquidity needs
  • Filing lacks contextual disclosure about purpose of sales or holdings post-transaction

Insights

TL;DR: A small scheduled Rule 144 sale (900 shares) follows multiple recent insider dispositions totaling over $4.24M.

The filing documents a planned disposal of 900 Class A shares on 10/10/2025 via Fidelity Brokerage Services LLC. The shares stem from an option granted on 08/10/2022 and are slated to be paid in cash, consistent with routine option exercise-and-sale activity.

Recent recorded sales by Michael Y. Chi span eight transactions from 07/23/2025 to 10/01/2025, with aggregate gross proceeds of $4,240,268.50, which is relevant for monitoring ongoing insider liquidity but is not a regulatory finding. Monitor near-term insider selling volumes and any public disclosures that provide context within 30 days.

Hims & Hers Health, Inc. notifica una vendita proposta di 900 Class A azioni tramite Fidelity Brokerage Services LLC in data 10/10/2025 con un valore di mercato aggregato di $52,425. Il dichiaratore indica che le azioni derivano da una opzione concessa il 08/10/2022 e mostrano pagamento in contanti nella data di vendita indicata. La pratica elenca recenti vendite di insider da Michael Y. Chi per un totale di $4,240,268.50 attraverso otto transazioni tra 07/23/2025 e 10/01/2025.

La notifica include la rappresentazione richiesta secondo cui il venditore non possiede informazioni materiali avverse non divulgate e identifica questa come una notifica di vendita proposta ai sensi della Rule 144. Nessun utile, guidance o altre metriche operative sono divulgate in questa forma.

Hims & Hers Health, Inc. aviso reporta una venta propuesta de 900 Class A acciones a través de Fidelity Brokerage Services LLC en 10/10/2025 con un valor de mercado agregado de $52,425. El declarante indica que las acciones provienen de una opción otorgada el 08/10/2022 y muestran pago en efectivo en la fecha de venta indicada. El registro lista ventas internas recientes por Michael Y. Chi por un total de $4,240,268.50 a través de ocho transacciones entre 07/23/2025 y 10/01/2025.

La notificación incluye la representación requerida de que el vendedor no posee información material adversa no divulgada e identifica esto como una noticia de venta propuesta conforme a la Regla 144. No se divulgan ganancias, directrices u otras métricas operativas en este formulario.

Hims & Hers Health, Inc. 공지는 Fidelity Brokerage Services LLC를 통해 900 Class A 주식을 2025/10/10에 매도할 것을 제안하며 총 시장 가치는 $52,425입니다. 제출자는 주식이 2022년 8월 10일에 부여된 옵션에서 파생되었으며 명시된 매도일에 현금 지급이 이루어짐을 표시합니다. 제출서는 Michael Y. Chi의 최근 내부자 매도가 $4,240,268.50에 이르고 8건의 거래에 걸쳐 07/23/2025 부터 10/01/2025 사이에 이루어졌다고 목록화합니다.

통지에는 매도인이 공개되지 않은 중요한 악재 정보가 없다는 요건적 진술이 포함되며 이를 Rule 144 매도 예고로 식별합니다. 수익, 가이던스 또는 다른 운영 지표는 이 양식에 기재되어 있지 않습니다.

Hims & Hers Health, Inc. notification informe d'une vente proposée de 900 Class A actions par l'intermédiaire de Fidelity Brokerage Services LLC le 10/10/2025 avec une valeur marchande $52,425 au total. Le déposant indique que les actions proviennent d'une option accordée le 08/10/2022 et montrent un paiement en espèces à la date de vente indiquée. Le dossier répertorie des ventes internes récentes par Michael Y. Chi pour un total de $4,240,268.50 réparties sur huit transactions entre 07/23/2025 et 10/01/2025.

L'avis comprend la représentation requise selon laquelle le vendeur ne possède pas d'informations matérielles défavorables non divulguées et l'identifie comme un avis de vente proposée conformément à la Rule 144. Aucun bénéfice, orientation ou autres métriques opérationnelles ne sont divulgués dans ce formulaire.

Hims & Hers Health, Inc. Mitteilung meldet einen vorgesehenen Verkauf von 900 Class A-Aktien über Fidelity Brokerage Services LLC am 10.10.2025 mit einem aggregierten Marktwert von $52,425. Der Einreicher gibt an, dass die Aktien aus einer am 08/10/2022 gewährten Option stammen und am angegebenen Verkaufstag eine Barzahlung zeigen. Die Einreichung listet jüngste Insiderverkäufe von Michael Y. Chi in Höhe von $4,240,268.50 über acht Transaktionen zwischen 07/23/2025 und 10/01/2025 auf.

Die Mitteilung enthält die erforderliche Darstellung, dass der Verkäufer keine nicht offengelegten wesentlichen nachteiligen Informationen besitzt und kennzeichnet dies als eine Rule 144-Mitteilung über den geplanten Verkauf. In diesem Formular werden weder Erträge, Guidance noch andere operative Kennzahlen offengelegt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the HIMS Form 144 disclose about the proposed sale?

It reports a proposed sale of 900 Class A shares through Fidelity Brokerage Services on 10/10/2025 with an aggregate market value of $52,425.

Who is recorded as selling shares in recent transactions for HIMS?

The filing lists insider sales by Michael Y. Chi between 07/23/2025 and 10/01/2025, totaling $4,240,268.50 in gross proceeds.

What is the origin of the 900 shares being sold?

The 900 shares derive from an option granted on 08/10/2022 and the filing indicates payment will be made in cash on the sale date.

Does the Form 144 state the seller has undisclosed material information?

By signature, the seller represents they do not know any undisclosed material adverse information about the issuer at the time of the notice.

Which exchange will the proposed sale occur on?

The proposed sale is listed for the NYSE using Fidelity Brokerage Services LLC as the broker.
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data

13.17B
203.02M
10.63%
88.99%
33.02%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States
SAN FRANCISCO